Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
|
|
Ikena Oncology, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Agreement and Plan of Merger, by and among Ikena Oncology, Inc., Portsmouth Merger Sub I, Inc., Portsmouth Merger Sub II, LLC, Pionyr Immunotherapeutics, Inc. and Fortis Advisors LLC, as securityholder agent",
"Certificate of Designations of Series A Non-Voting Convertible Preferred Stock",
"Contingent Value Rights Agreement, by and between Ikena Oncology, Inc. and Computershare Trust Company N.A, as rights agent",
"Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction" |
|
|
|